Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2019 Aug 2;168:384–391. doi: 10.1016/j.bcp.2019.07.026

Table 1:

Summary of drug uptake transporters involved in protein-protein interaction

Transporter Interaction Partner Functional Change?* Expression Change?*
NTCP NTCP No N/A
SOAT
OATP1B1 OATP1B1
OATP1B3 OATP1B3 No No
OATP1B1 N/A N/A
NTCP N/A N/A
OSTα OSTβ Required for function Required for membrane expression
OCT1 OCT1 No N/A
OCT2 OCT2 N/A N/A
LAPTM4A N/A N/A
CD63 N/A N/A
OAT1 OAT1
OAT3 OAT3 N/A N/A
Caveolin-1 ↑ due to gain of protein-cytoskeletal interaction Redistribution to non-LRD-rich compartments
β-actin
Myosin
OCTN2 Caveolin-1 N/A N/A
Flotillin N/A N/A
*

Functional and expression change means that the potential changes happened to the target transporter by the interactions with the partner transporters. Arrows represent the increase (↑) or decrease (↓) of function or membrane expression.